Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Dbw Investments (14) Ltd investment portfolio
Dbw Investments (14) Ltd has made numerous investments in companies such as Jellagen, Sterling Deeside, and Hexigone Inhibitors within the DeepTech sector.
vc
Portfolio
12
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (12)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Bivictrix Therapeutics Limited BiVictriX Therapeutics develops next‑generation multispecific antibody‑drug conjugates (ADCs) using its proprietary Bi‑Cygni® platform to create highly cancer‑selective therapies for solid tumours and haematological malignancies. | Healthcare & Life Sciences | Macclesfield | Confirmed | 2025-06-21 |
| Ceryx Medical Limited Ceryx Medical designs and manufactures bioelectronic medical devices that employ patented microchip and biomimetic technology to treat serious heart conditions such as heart failure, targeting patients and clinicians in the cardiovascular care market. | Healthcare & Life Sciences | Cardiff | Confirmed | 2026-03-27 |
Shareholding changes (7)
Dbw Investments (14) Ltd's positions across portfolio companies2026
- A ORDINARY 9,433,000 → 0
- A ORDINARY 31,102 → 0
Articles (2)
- 5 Jun 2026
- Hexigone Inhibitors Secures £174k in Latest Funding Round22 Apr 2026Hexigone Inhibitors